Immuno-oncology @Sanofi | Previously @BBS_Harvard @PittetLab @MGHCSB
Joined March 2018
- Tweets 137
- Following 273
- Followers 225
- Likes 662
3 Photos and videos
Pinned Tweet
30 Mar 2023
Excited to share my PhD work in the @PittetLab, published today in @CellCellPress! We show that immunotherapy can expand a distinct interferon-responsive neutrophil state that contributes to successful responses to therapy: sciencedirect.com/science/ar…
30 Mar 2023
❔What is special about an immune system that successfully attacks tumors, compared to one that doesn’t?
Our new study in @CellCellPress led by @jgungabeesoon, @Nich and @Mate_Kiss_ aimed to address this question. A joint work with the great @KleinLabHMS
authors.elsevier.com/a/1gqie…
4
27
4,309
Jeremy Gungabeesoon retweeted
7 Aug 2023
📢 Research Alert! 🧬🔬 🩺 We are super excited that our latest study, led by the great @RubenBill5 & Asa Wirapati, is out: science.org/doi/full/10.1126…
We set out to shed some light on the tumor microenvironment and its impact on cancer progression.
🧵
6
30
122
21,835
SPOTLIGHT: @BBS_Harvard @PittetLab @jgungabeesoon demonstrated that neutrophils exhibit remarkable plasticity and could acquire an antitumor phenotype in response to immunotherapy. bit.ly/3KU2Nsb
3
6
894
Jeremy Gungabeesoon retweeted
1 Apr 2023
The findings suggest that researchers may be able to manipulate neutrophils to make cancer therapies more effective hms.harvard.edu/news/how-low…
6
49
225
48,617
31 Mar 2023
Read more about my PhD work here! @PittetLab @KleinLabHMS
30 Mar 2023
Neutrophils — the most common cell type in the immune system — play a key role in immunotherapy success hvrd.me/vv3X50Nw2xn
1
4
463
Jeremy Gungabeesoon retweeted
6 Dec 2021
The Garris Lab @MGHCSB @MGH_RI @harvardmed is looking for curious and driven postdoctoral fellows who want to investigate the biology of #dendriticcells in cancer growth and therapy. Interested candidates should send their CV and cover letter to positions@garrislab.com
14
30
Jeremy Gungabeesoon retweeted
3 Aug 2021
1/ 🤩Whoah! I'm so excited to be a part of this awesome @MempelThorsten study, led by @DiPilato and colleagues. It shows a mechanism by which "good" cells (i.e. antitumor CD8 T cells) can survive in tumors to do their job.
cell.com/cell/fulltext/S0092…
3
16
62
Jeremy Gungabeesoon retweeted
2 Aug 2021
The intrepid Mauro (now @DiPilatoLab) and team did it again: CXCR6 enables CTL to control tumors by guiding their interactions with CCR7 cDC in perivascular survival niches of the tumor stroma. Thanks to our fantastic collaborators. See 🧵 for details.
cell.com/cell/fulltext/S0092…
10
39
146
Jeremy Gungabeesoon retweeted
14 Jul 2021
Immune networks within the glial cell ecosystem maintain brain health.
Our latest is out today in @nature. Astrocytic interleukin-3 programs microglia and limits Alzheimer’s disease.
This was a wonderful collaboration with @RudyTanzi and his team. 1/
nature.com/articles/s41586-0…
12
49
204
Jeremy Gungabeesoon retweeted
12 Jul 2021
Are brain borders the new bone marrow?
New work from the @mzhlab complements recent findings from the @TheColonnaLab and @jonykipnis labs to show brain-dedicated B-lymphopoiesis!
A pleasure to contribute our little grain
nature.com/articles/s41593-0…
6
22
122
Jeremy Gungabeesoon retweeted
6 Jul 2021
It’s out! My PhD work focusing on toxicities associated with anti-cancer immunotherapy drugs:
immunology.sciencemag.org/co…
And my first #tweetorial brought to you by @PittetLab where you can learn all about our findings! x.com/PittetLab/status/14116…
4 Jul 2021
0/ Published today in Science Immunology! Work from our lab investigating immunotherapy-driven toxicities (immune related adverse events, a.k.a. irAEs), which are a major clinical problem in cancer immunotherapy clinics. #tweetorial
immunology.sciencemag.org/co…
6
20
Jeremy Gungabeesoon retweeted
5 Jul 2021
A new @MGH_RI, @harvardmed study pinpoints a potential target to offset adverse effects from #cancer #immunotherapy, revealing in mice that obstructing inflammatory neutrophils in the liver prevented the toxicity of anti-CD40 agonist therapy: fcld.ly/j1e5xr4
16
25
Jeremy Gungabeesoon retweeted
4 Jul 2021
👉Macrophages & neutrophils may drive toxicities after #immunotherapy, but NOT dendritic cells. Instead, dendritic cells, incl. DC3 (also called, LAMP3 DC, mregDC) may be key for antitumor immunity. This could be important for next gen treatments.
doi.org/10.1126/sciimmunol.a…
2
77
260
Jeremy Gungabeesoon retweeted
4 Jul 2021
0/ Published today in Science Immunology! Work from our lab investigating immunotherapy-driven toxicities (immune related adverse events, a.k.a. irAEs), which are a major clinical problem in cancer immunotherapy clinics. #tweetorial
immunology.sciencemag.org/co…
3
69
208
Jeremy Gungabeesoon retweeted
19 May 2021
Pleased to announce my latest study @RockefellerUniv published in @ScienceTM. stm.sciencemag.org/content/1… In this study we provide proof of concept for bladder infused CD40 agonistic antibodies as a local treatment for bladder cancer.
11
25
108
Jeremy Gungabeesoon retweeted
16 May 2021
Low-carb, high-fat diets—including the popular “ketogenic” diet—may not be any more effective at keeping obesity at bay than those that balance calorie intake with energy expenditure, a new #SciencePerspective suggests. fcld.ly/oeb435c #WeekendReads
11
125
366
Jeremy Gungabeesoon retweeted
17 Mar 2021
👉The @PittetLab is hiring a #bioinformatician to pursue our work on the tumor immune microenvironment.
All this in an amazing place isrec.ch/en/agora 🇨🇭... and with a great bioinformatics network @KleinLabHMS @carmonation !
Please share or let us know if interested!
3
21
29
Jeremy Gungabeesoon retweeted
4 Jan 2021
In their #JEMCancerFocus review, @gengerhard @PittetLab et al reveal the conservation of human tumor-infiltrating dendritic cell states, explore DC state conservation in mice, & discuss the origins, behavior & functions of these cells bit.ly/2LQ0pqv
6
13
Jeremy Gungabeesoon retweeted
18 Dec 2020
😀Happy to share our latest work on tumor-infiltrating dendritic cells (DC)! doi.org/10.1084/jem.20200264 We know these cells can play key antitumor functions, but they require more attention and could become important targets for cancer #immunotherapy. @MGHCSB @MGH_RI @harvardmed 1/n
4
27
88
Jeremy Gungabeesoon retweeted
30 Aug 2020
The Harvard Medical School Immunology Webinar Series kicks off the Fall program this Wed Sep 2nd, 4pm EST with Dr Joanne Flynn. Check out the full schedule: dms.hms.harvard.edu/immunolo…
Zoom link: harvard.zoom.us/j/9495334099… Passcode: 840345
Open to all- please retweet!
10
363
565